Features of the COVID-19 in lung tissue damage admitted to hospital

Abstract

The COVID-19 pandemic continues to spread despite all the efforts of the medical community.

The aim of the study – to identify the features of a new coronavirus infection (COVID-19) with lung tissue damage in men and women receiving inpatient treatment.

Material and methods. The method of continuous sampling selected 225 patients admitted to inpatient treatment. The patients were divided in 2 groups: the 1st group – men (n=85), the 2nd group – women (n=140). Statistical processing was carried out using the IBM SPSS Statistics 22.0 program.

Results. In a comprehensive study of the features of lung tissue damage by the new coronavirus infection SARS-CoV-2 in men and women was found that women received inpatient treatment more often, after ineffective outpatient treatment, the general serious condition at admission was more typical for women who had a positive result of a PCR-test for the detection of SARS-CoV-2 (p=0.038). In the presence of general clinical manifestations complaints of loss of sense of smell were more often presented by women (p=0.020). According to laboratory studies in the indicators of general clinical and biochemical blood tests, on average men often have higher levels of creatinine (p<0.001), women more often have elevated levels of ESR (p=0.003), erythrocytes (p<0.001), CRP (p=0.042) and decreased hemoglobin (p=0.029).

Conclusion. In the first wave of the Wuhan pandemic of the SARS-CoV-2 virus strain women prevailed among patients admitted to inpatient treatment with lung tissue damage after ineffective outpatient treatment (p=0.038). There was a commonality in age and clinical manifestations, of the complaints in women, only loss of sense of smell was more common (p=0.020). The erythrocytosis detected in women, increased ESR and CRP, lower hemoglobin and creatinine levels are not specific for COVID-19. There were no statistically significant differences in the terms of hospitalization and the fatal outcome of the disease between men and women.

Keywords:COVID-19; pandemic; gender differences; inpatient treatment

Funding. The study was not sponsored.

Conflict of interest. The authors declare that there is no conflict of interest.

Contribution. Concept and design of the study – Povalyaeva L.V., Borodulina E.A.; collection and processing of the material – Vdoushkina E.S., Sukhanova A.Е., Vasneva Zh.P.; statistical processing – Gerasimov A.N.; writing of the text – Vdoushkina E.S., Yakovleva E.V.; editing – Povalyaeva L.V., Borodulina E.A.

For citation: Povalyaeva L.V., Vdoushkina E.S., Borodulina E.A., Yakovleva E.V., Vasneva Zh.P., Gerasimov A.N., Sukhanova A.E. Features of the COVID-19 in lung tissue damage in men and women admitted to hospital. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2022; 11 (3): 28–34. DOI: https://doi.org/10.33029/2305-3496-2022-11-3-28-34

References

1. Ievlev E.N., Badakhshina R.R., Danilov T.V. Moderate to severe risk factors for new coronavirus infection (COVID-19). Modern Science [Modern Science]. 2020; 12 (2): 109–11. (in Russian)

2. Smetanina S.V. Features of the course of a new coronavirus infection: current data. Moskovskaya meditsyna [Moscow Medicine]. 2021; 3 (43): 14–6. (in Russian)

3. Nekaeva E.S., Bol’shakova A.E., Malysheva E.S., Galova E.A., Makarova E.V., Nekrasova T.A., et al. Gender characteristics of the course of the new coronavirus infection COVID-19 in adults. Sovremennye tekhnologii v meditsine [Modern Technologies in Medicine]. 2021; 13 (4): 16–26. (in Russian)

4. Kasholkina E.A., Godkov M.A. Gender characteristics of the dynamics of detecting COVID-19 during the epidemic. Klinicheskaya laboratornaya diagnostika [Clinical Laboratory Diagnostics]. 2021; 66 (S4): 31. (in Russian)

5. Sharipova S.Z., Zholdybaeva G.A. Features of the CT picture in the new coronavirus infection COVID-19. Molodoy uchoniy [Young Scientist]. 2021; 27 (369): 95–102. (in Russian)

6. Akimkin V.G., Kuzin S.N., Semenenko T.A., et al. Gender and age characteristics of patients with COVID-19 at different stages of the epidemic in Moscow. Problemy osobo opasnykh infektsiy [Problems of Particularly Dangerous Infections]. 2020; (3): 27–35. (in Russian)

7. Vechorko V.I., Evsikov E.M., Sokolova N.A., Kirilyuk E.V., Nestruev M.M. Gender differences in diagnostic and treatment measures in patients with COVID-19 and features of their inpatient rehabilitation. Profilakticheskaya meditsina [Preventive Medicine]. 2020; 23 (5): 117–23. (in Russian)

8. Jin J.M., Bai P., He W., et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020; 8: 152. DOI: https://doi.org/10.3389/fpubh.2020.00152

9. Haitao T., Vermunt J.V., Abeykoon J., et al. COVID-19 and sex differences: mechanisms and biomarkers. Mayo Clin Proc. 2020; 95 (10): 2189–203. DOI: https://doi.org/10.1016/j.mayocp.2020.07.024

10. Vdoushkina E.S., Borodulin B.E., Skoptsova N.V., et al. Community-acquired pneumonia and HIV infection. Gender characteristics. Vestnik sovremennoy klinicheskoy meditsiny [Bulletin of Modern Clinical Medicine]. 2018; 11 (2): 19–23. (in Russian)

11. Puzyreva L.V., Mordyk A.V., Rudenko S.A., et al. Influence of HIV infection and gender differences on the formation of mortality in patients at an anti-tuberculosis hospital. Tuberkulez i bolezni legkikh [Tuberculosis and Lung Diseases]. 2017; 95 (6): 30–5. (in Russian)

12. Galasso V., Pons V., Profeta P., еt al. Gender differences in COVID-19 attitudes and behavior: panel evidence from eight countries. Proc Natl Acad Sci USA. 2020; 117 (44): 27 285–91. DOI: https://doi.org/10.1073/pnas.2012520117

13. Klein S.L., Jedlicka A., Pekosz A. The Xs and Y of Immune responses to viral vaccines. Lancet Infect Dis. 2010; 10 (5): 338–49.

14. Fan H., Dong G., Zhao G., et al. Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of Sle related to estrogen. J Immunol Res. 2014; 2014: 814598.

15. Wikby A., Mansson I.A., Johansson B., еt al. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20–100 years of age. Biogerontology. 2008; 9 (5): 299–308.

16. Villacres M.C., Longmate J., Auge C., еt al. Predominant type 1 Cmv-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion. Hum Immunol. 2004; 65 (5): 476–85.

17. Hewagama A., Patel D., Yarlagadda S., еt al. Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis. Genes Immun. 2009; 10 (5): 509–16.

18. Zhao Y., Zhao Z., Wang Y., еt al. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. Am J Respir Crit Care Med. 2020; 202 (5): 756–9.

19. Culebras E., Hernández F. ACE2 is on the X chromosome: could this explain COVID-19 gender differences? Eur Heart J. 2020; 41 (32): 3095. DOI: https://doi.org/10.1093/eurheartj/ehaa521

20. Bukowska A., Spiller L., Wolke C., еt al. Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp Biol Med (Maywood). 2017; 242 (14): 1412–23.

21. Li K., Wohlford-Lenane C., Perlman S., еt al. Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis. 2016; 213 (5): 712–22. DOI: https://doi.org/10.1093/infdis/jiv499

22. Liao D., Zhou F., Luo L., et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020; 7: 71–78. DOI: https://doi.org/10.1016/S2352-3026(20)30217-9 Epub 2020 July 10.

23. Wu C., Chen X., Cai Y., et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180: 1–11. DOI: https://doi.org/10.1001/jamainternmed.2020.0994

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)

Journals of «GEOTAR-Media»